Join the Diabetes, Type 2 group to help and get support from people like you.
Diabetes, Type 2 News (Page 4)
Related terms: Noninsulin-dependent Diabetes, Type 2 Diabetes, Diabetes, Type 2
FDA Approves Merilog (insulin-aspart-szjj), a Biosimilar to NovoLog
February 14, 2025 – Today, the U.S. Food and Drug Administration approved Merilog (insulin-aspart-szjj) as biosimilar to NovoLog (insulin aspart) for the improvement of glycemic control in adults...
Diabetes, Dyslipidemia Screening Rates Low After Pregnancy, Even for Those With HTN, GDM
FRIDAY, Feb. 21, 2025 – Patients with pregnancy-related hypertension (HTN) or diabetes are more likely to be screened for diabetes and dyslipidemia after delivery, but screening rates remain low for...
Certain Glucose-Lowering Meds Associated With Lower Risk for COPD Exacerbations
FRIDAY, Feb. 21, 2025 – For patients with type 2 diabetes (T2D) and chronic obstructive pulmonary disorder (COPD), sodium-glucose cotransporter-2 inhibitors (SGLT-2is) and glucagon-like peptide-1...
FDA Approves Merilog, First Rapid-Acting Insulin Biosimilar for Patients With Diabetes
WEDNESDAY, Feb. 19, 2025 – The U.S. Food and Drug Administration has approved Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with...
FDA Approves Merilog, First Rapid-Acting Insulin Biosimilar for Patients With Diabetes
WEDNESDAY, Feb. 19, 2025 – The U.S. Food and Drug Administration has approved Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with...
Docs Don't Track Pregnancy Complications That Threaten Long-Term Health
WEDNESDAY, Feb. 19, 2025 – Women who develop a complication like diabetes or high blood pressure during pregnancy are at higher risk of stroke or heart disease in the years after delivery....
Many With Overweight, Obesity Discontinue GLP-1 Receptor Agonists Within One Year
FRIDAY, Jan. 14, 2025 – Many patients with overweight or obesity discontinue glucagon-like peptide-1 (GLP-1) receptor agonist therapy within one year, with higher discontinuation rates seen for...
Belly Fat, Diabetes and Drinking Doubles Liver Disease Risk
THURSDAY, Feb. 13, 2025 – If you've got a big belly, diabetes or high blood pressure, you may want to limit your alcohol, experts warn, as drinking could significantly raise your odds for serious...
Wrong Smartphone Settings Can Lead to Missed Alerts From Linked Diabetes Devices
TUESDAY, Feb. 11, 2025 – The U.S. Food and Drug Administration is urging all patients with smartphone-compatible diabetes devices to check their phone configurations to ensure all safety alerts are...
More Evidence Ozempic Can Curb Alcoholism
WEDNESDAY, Feb. 12, 2025 – Yet another study is supporting the notion that the blockbuster GLP-1 drug Ozempic can help problems drinkers curb their intake. The research found that, compared to...
Most Americans Keep Chronic Health Conditions Hidden at Work: Poll
TUESDAY, Feb. 11, 2025 – Chronic ills like heart disease, asthma or diabetes afflict a majority of U.S. workers, but 60% of those affected say they've kept their health issue a secret from...
Age Differences Seen in Efficacy of Type 2 Diabetes Treatments
TUESDAY, Feb. 11, 2025 – Age differences are seen in the efficacy of treatments for type 2 diabetes, according to a study published online Feb. 3 in the Journal of the American Medical Association....
GLP-1 Meds Can Work Wonders for Kidney Health
TUESDAY, Feb. 11, 2025 – Ozempic, Wegovy, Saxenda, Trulicity: These and other GLP1-RA diabetes/weight-loss meds can also boost outcomes for folks battling chronic kidney disease, new research shows....
Can GLP-1 Meds Harm Your Eyes?
MONDAY, Feb. 10, 2025 – Yes, rare cases of vision issues have arisen in people taking popular GLP-1 weight loss drugs, but the jury's out on whether the medications caused the eye trouble, according...
New Facial Plastic Surgery Survey Illustrates Impact of GLP-1 Receptor Agonists
FRIDAY, Feb. 7, 2025 – Glucagon-like peptide-1 receptor agonist (GLP-1 RA) medications for weight loss are significantly transforming the field of facial plastic surgery, according to the results of...
Further information
Related condition support groups
Related drug support groups
metformin, Ozempic, Victoza, Mounjaro, Lantus, semaglutide, Trulicity, glipizide, Rybelsus, view more... Farxiga, Jardiance, Lantus Solostar, Humalog, Novolog, liraglutide, Janumet, insulin glargine, tirzepatide, Januvia, insulin lispro, Bydureon, Tresiba, Levemir, dulaglutide, Glucophage, Invokana, insulin degludec, Humulin N